highlights of the day: lymphoma presented by sonali smith at 2014 asco annual meeting
TRANSCRIPT
Diffuse Large B-cell Lymphoma: How can we improve on R-CHOP?
Presented By Sonali Smith at 2014 ASCO Annual Meeting
Rituximab clearance by age and gender and study design
Presented By Sonali Smith at 2014 ASCO Annual Meeting
Diffuse Large B-cell Lymphoma: How can we improve on R-CHOP?
Presented By Sonali Smith at 2014 ASCO Annual Meeting
Synthetic lethality of lenalidomide in ABC-DLBCL and clinical proof of principle
Presented By Sonali Smith at 2014 ASCO Annual Meeting
PFS by GCB vs. non-GCB Subtype* in RCHOP Case-matched Control and R2CHOP Patients
Presented By Sonali Smith at 2014 ASCO Annual Meeting
OS by GCB vs. non-GCB Subtype in RCHOP Case-matched Control and R2CHOP Patients
Presented By Sonali Smith at 2014 ASCO Annual Meeting
PFS by Treatment Type in GCB vs. non-GCB Subtype
Presented By Sonali Smith at 2014 ASCO Annual Meeting
Abstract 8502:<br />246 patients with reviewed postinduction PET-CT<br />
Presented By Sonali Smith at 2014 ASCO Annual Meeting
Postinduction PET status (cut-off ≥4) <br />and Overall Survival
Presented By Sonali Smith at 2014 ASCO Annual Meeting
CHOP ± Rituximab in MCL: <br />Progression-Free Survival
Presented By Sonali Smith at 2014 ASCO Annual Meeting
Approved agents for R/R MCL<br />(Variable intensity of prior Rx among studies)
Presented By Sonali Smith at 2014 ASCO Annual Meeting
Superior PFS by IRC with VR-CAP vs R-CHOP: 59% improvement
Presented By Sonali Smith at 2014 ASCO Annual Meeting